A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers
NCT00501683
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
Interventions
DRUG:
Radiolabelled GSK189075
Sponsor
GlaxoSmithKline